EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Clinical utility gene card for: B4GALT7-defective congenital disorder of glycosylation.
|
27827381 |
2017 |
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The Ehlers-Danlos syndromes, rare types.
|
28306225 |
2017 |
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
This study expands the phenotypic spectrum of B4GALT7 mutations, initially described as responsible for the progeroid variant of Ehlers-Danlos syndrome.
|
24755949 |
2015 |
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
This study expands the phenotypic spectrum of B4GALT7 mutations, initially described as responsible for the progeroid variant of Ehlers-Danlos syndrome.
|
24755949 |
2015 |
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Our report identifies a novel mutation in B4GALT7 causing the progeroid variant of Ehlers-Danlos syndrome and contributes an extensive phenotypic characterization of a patient with the syndrome.
|
23956117 |
2013 |
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A novel missense mutation in the galactosyltransferase-I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers-Danlos syndrome resembling the progeroid type.
|
15211654 |
2004 |
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
Biomarker
|
disease |
BEFREE |
Galactosyltransferase I is a gene responsible for progeroid variant of Ehlers-Danlos syndrome: molecular cloning and identification of mutations.
|
12417421 |
2002 |
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Molecular basis for the progeroid variant of Ehlers-Danlos syndrome. Identification and characterization of two mutations in galactosyltransferase I gene.
|
10506123 |
1999 |
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Glycosaminoglycan-free small proteoglycan core protein is secreted by fibroblasts from a patient with a syndrome resembling progeroid.
|
3631078 |
1987 |
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1
|
0.730 |
Biomarker
|
disease |
CTD_human |
|
|
|
EHLERS-DANLOS SYNDROME, PROGEROID FORM
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
A novel missense mutation in the galactosyltransferase-I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers-Danlos syndrome resembling the progeroid type.
|
15211654 |
2004 |
EHLERS-DANLOS SYNDROME, PROGEROID FORM
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Craniofacial Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
A zebrafish screen for craniofacial mutants identifies wdr68 as a highly conserved gene required for endothelin-1 expression.
|
16759393 |
2006 |
Lethal skeletal dysplasia
|
0.110 |
Biomarker
|
disease |
BEFREE |
These findings expand the phenotype of B4GALT7-related linkeropathies to include lethal skeletal dysplasia due to more severe loss of function.
|
31278392 |
2019 |
Dwarfism
|
0.110 |
Biomarker
|
disease |
BEFREE |
To date only 7 patients with β4GALT7-deficiency (spEDS-B4GALT7) have been described and their clinical data suggested that, in addition to short stature and muscle hypotonia, radioulnar synostosis, hypermetropia, and delayed cognitive development might be a hallmark of this specific type of spEDS.
|
28882145 |
2017 |
Radioulnar Synostosis
|
0.110 |
Biomarker
|
disease |
BEFREE |
To date only 7 patients with β4GALT7-deficiency (spEDS-B4GALT7) have been described and their clinical data suggested that, in addition to short stature and muscle hypotonia, radioulnar synostosis, hypermetropia, and delayed cognitive development might be a hallmark of this specific type of spEDS.
|
28882145 |
2017 |
Global developmental delay
|
0.110 |
Biomarker
|
disease |
BEFREE |
To date only 7 patients with β4GALT7-deficiency (spEDS-B4GALT7) have been described and their clinical data suggested that, in addition to short stature and muscle hypotonia, radioulnar synostosis, hypermetropia, and delayed cognitive development might be a hallmark of this specific type of spEDS.
|
28882145 |
2017 |
Dwarfism
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Radioulnar Synostosis
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Lethal skeletal dysplasia
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Ehlers-Danlos Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our report extends the phenotypic spectrum of B4GALT7-associated spondylodysplastic Ehlers-Danlos syndrome and reports results of growth hormone treatment for patients with this rare disorder.
|
30914273 |
2019 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Co-regulatory networks of human serum proteins link genetics to disease.
|
30072576 |
2018 |